Bone formation is enhanced by thrombin‐related peptide TP508 during distraction osteogenesis
Authors:
- Gang LiGLGang Li
- Hali WangHWHali Wang
- 1 January 2005
- journal article
- Published by Wiley in Journal of Orthopaedic Research
- Vol. 23 (1) , 196-202
Abstract
The thrombin‐related peptide, TP508, has been shown to promote soft tissue healing and fracture repair. One possible clinical application of TP508 is to accelerate bone regeneration during distraction osteogenesis, which is a lengthy procedure involving significant complications. In this study, we tested the ability of TP508 to accelerate the consolidation phase of distraction osteogenesis in a rabbit model of leg lengthening. Twenty‐three rabbits had left tibiae lengthened for 1 cm over a period of 6 days. TP 508 (0, 30 and 300 μg in 300 μl saline) was injected into the distraction gaps at the beginning and the end of the lengthening phase, and all the animals were killed 2 weeks after lengthening. By the end of experiment, more animals in the TP508 treated groups had complete bony union of the distraction gaps when compared to the saline treated group. pQCT examination of the regenerates demonstrated a significantly greater bone mineral density (BMD) in the TP508 treated groups relative to the saline control group, but no statistical difference in the BMD was found between the two dosages of TP508. Bone consolidation and bone remodeling was far advanced in the TP508 300 μg treated group, and the regenerates mainly consisted of well‐vascularized woven bone. In contrast, in the group that received the 30 μg TP508 treatment, focal bone defects and discontinuities of the new cortices were evident in some but not all animals. In the saline control group a majority of the animals showed large amounts of fibrous and cartilaginous tissues in the regenerates, and none of the regenerates had completed consolidation. This study has demonstrated that local application of TP508 enhanced bone formation and consolidation during distraction osteogenesis in the rabbit. The findings indicate that TP508 may be useful in promoting osteogenesis in situations when augmentative treatment for bone formation and consolidation are needed. © 2004 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved.Keywords
This publication has 16 references indexed in Scilit:
- Thrombin peptide, TP508, stimulates angiogenic responses in animal models of dermal wound healing, in chick chorioallantoic membranes, and in cultured human aortic and microvascular endothelial cellsGeneral Pharmacology: The Vascular System, 2000
- Acceleration of full‐thickness wound healing in normal rats by the synthetic thrombin peptide, TP508Wound Repair and Regeneration, 2000
- TISSUES FORMED DURING DISTRACTION OSTEOGENESIS IN THE RABBIT ARE DETERMINED BY THE DISTRACTION RATE: LOCALIZATION OF THE CELLS THAT EXPRESS THE mRNAs AND THE DISTRIBUTION OF TYPES I AND II COLLAGENSCell Biology International, 2000
- Effect of lengthening rate on angiogenesis during distraction osteogenesisJournal of Orthopaedic Research, 1999
- Thrombin Peptide, TP508, Induces Differential Gene Expression in Fibroblasts through a Nonproteolytic Activation PathwayExperimental Cell Research, 1999
- Assessment of cell proliferation in regenerating bone during distraction osteogenesis at different distraction ratesJournal of Orthopaedic Research, 1997
- Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides.Journal of Clinical Investigation, 1992
- Leg LengtheningClinical Orthopaedics and Related Research, 1989
- The Tension-Stress Effect on the Genesis and Growth of TissuesClinical Orthopaedics and Related Research, 1989
- The Tension-Stress Effect on the Genesis and Growth of TissuesClinical Orthopaedics and Related Research, 1989